Despite decades of intense global research, initiatives to slow the clinical progression of AD have largely failed. This is attributable not only to the complexity inherent to AD, but also to the fact that AD is believed to be the result of myriad chronic, and perhaps even lifelong, physiological and genetic alterations that may not be immediately reversible. To evaluate the potential for early intervention for AD in pre-clinical populations, """"""""lifestyle factors"""""""" known to increase the risk of cardiovascular diseases (cardiovascular risk factors (CvRFs)), have recently been evaluated as potential risk factors of AD. For example, recent evidence indicates that late life insulin resistance (a feature of non-insulin dependent diabetes mellitus), known to increase the risk of cardiovascular disease, increases the risk of AD dementia by >2-4 fold. Additionally, recent studies have reported decreased insulin insensitivity in the AD brain, and shown that insulin-sensitizing drugs in AD can improve cognition. To identify biological markers of the CvRF insulin resistance, and to further explore the relationship of insulin resistance to AD and early pre-clinical AD, we have studied insulin resistance in vivo using as experimental diabetogenic mouse model. Encouragingly, in recent high throughput genomic studies we identified several families of genes whose expression were altered under conditions of diabetogenic diet induced insulin resistance, and found these genes to be comparably regulated in the AD brain as a function of the clinical progression of AD dementia. This novel discovery provides a critical biological link between AD and insulin resistance, and supports further study of insulin resistance in the context of AD etiology. Further, in preliminary studies using a transgenic mouse model of AD, we found that diet induced insulin resistance significantly promoted beta-amyloid peptide generation in the brain of a transgenic mouse model of AD (Tg 2576 mice). In this application we propose to continue to investigate the regulation of these novel biomarker gene products of """"""""insulin resistance"""""""" in AD and in AD model systems, and explore their specific relationship to AD-type neuropathology and cognition. At the completion of the funding period it is expected that we will develop an understanding of the biological relationship of insulin resistance to AD, yield feasibility data for ongoing and future anti-diabetic drug clinical trials in AD, and generate biological criteria for diagnosing/monitoring this CvRF in AD dementia and populations at high-risk of AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG002219-27
Application #
7379962
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
27
Fiscal Year
2007
Total Cost
$268,756
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Katsumata, Yuriko; Nelson, Peter T; Ellingson, Sally R et al. (2017) Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2. Neurobiol Aging 53:193.e17-193.e25
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Mancuso, Nicholas; Shi, Huwenbo; Goddard, Pagé et al. (2017) Integrating Gene Expression with Summary Association Statistics to Identify Genes Associated with 30 Complex Traits. Am J Hum Genet 100:473-487
Zhu, Lingxue; Lei, Jing; Devlin, Bernie et al. (2017) TESTING HIGH-DIMENSIONAL COVARIANCE MATRICES, WITH APPLICATION TO DETECTING SCHIZOPHRENIA RISK GENES. Ann Appl Stat 11:1810-1831
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Jasinska, Anna J; Zelaya, Ivette; Service, Susan K et al. (2017) Genetic variation and gene expression across multiple tissues and developmental stages in a nonhuman primate. Nat Genet 49:1714-1721
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121

Showing the most recent 10 out of 294 publications